A detailed history of Charles Schwab Investment Management Inc transactions in Alector, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 760,606 shares of ALEC stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
760,606
Previous 666,461 14.13%
Holding current value
$1.46 Million
Previous $3.03 Million 17.42%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.34 - $6.58 $408,589 - $619,474
94,145 Added 14.13%
760,606 $3.55 Million
Q2 2024

Aug 12, 2024

SELL
$4.19 - $6.23 $34,898 - $51,889
-8,329 Reduced 1.23%
666,461 $3.03 Million
Q1 2024

May 08, 2024

BUY
$5.69 - $8.08 $997,235 - $1.42 Million
175,261 Added 35.09%
674,790 $4.06 Million
Q4 2023

Feb 06, 2024

BUY
$3.77 - $8.39 $65,247 - $145,205
17,307 Added 3.59%
499,529 $3.99 Million
Q3 2023

Nov 08, 2023

BUY
$5.2 - $8.77 $65,358 - $110,230
12,569 Added 2.68%
482,222 $3.12 Million
Q2 2023

Aug 09, 2023

BUY
$5.86 - $7.93 $62,737 - $84,898
10,706 Added 2.33%
469,653 $2.82 Million
Q1 2023

May 11, 2023

BUY
$5.85 - $9.84 $20,463 - $34,420
3,498 Added 0.77%
458,947 $2.84 Million
Q4 2022

Feb 13, 2023

BUY
$6.88 - $9.55 $70,024 - $97,199
10,178 Added 2.29%
455,449 $4.2 Million
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $141,383 - $227,871
17,263 Added 4.03%
445,271 $4.21 Million
Q2 2022

Aug 15, 2022

BUY
$7.65 - $14.24 $40,636 - $75,642
5,312 Added 1.26%
428,008 $4.35 Million
Q1 2022

May 13, 2022

BUY
$13.02 - $20.78 $129,262 - $206,303
9,928 Added 2.41%
422,696 $6.02 Million
Q4 2021

Feb 11, 2022

BUY
$19.35 - $25.54 $128,793 - $169,994
6,656 Added 1.64%
412,768 $8.52 Million
Q3 2021

Nov 16, 2021

BUY
$21.65 - $39.49 $691,046 - $1.26 Million
31,919 Added 8.53%
406,112 $9.27 Million
Q2 2021

Aug 16, 2021

BUY
$15.5 - $22.48 $442,633 - $641,961
28,557 Added 8.26%
374,193 $7.8 Million
Q1 2021

May 17, 2021

BUY
$14.84 - $22.23 $170,600 - $255,556
11,496 Added 3.44%
345,636 $6.96 Million
Q4 2020

Feb 16, 2021

SELL
$9.4 - $16.7 $5,969 - $10,604
-635 Reduced 0.19%
334,140 $5.06 Million
Q3 2020

Nov 13, 2020

BUY
$10.54 - $24.96 $677,416 - $1.6 Million
64,271 Added 23.76%
334,775 $3.53 Million
Q2 2020

Aug 14, 2020

BUY
$21.87 - $33.11 $931,530 - $1.41 Million
42,594 Added 18.69%
270,504 $6.61 Million
Q1 2020

May 15, 2020

BUY
$16.25 - $35.28 $739,960 - $1.61 Million
45,536 Added 24.97%
227,910 $5.5 Million
Q4 2019

Feb 07, 2020

BUY
$14.17 - $20.3 $56,991 - $81,646
4,022 Added 2.26%
182,374 $3.14 Million
Q3 2019

Nov 08, 2019

BUY
$14.42 - $22.2 $1.75 Million - $2.7 Million
121,608 Added 214.31%
178,352 $2.57 Million
Q2 2019

Aug 09, 2019

BUY
$16.26 - $26.42 $158,876 - $258,149
9,771 Added 20.8%
56,744 $1.08 Million
Q1 2019

May 14, 2019

BUY
$15.97 - $22.5 $750,158 - $1.06 Million
46,973 New
46,973 $880,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.